A common clinical finding in SLE is loss of tolerance to self-DNA, in which patients develop high-affinity pathogenic autoantibodies against histone-bound DNA, antinuclear Abs (ANAs), and anti–double-stranded DNA Abs (anti-dsDNA Abs) (2–4). This evidence concerns the gene DDX41 and systemic lupus erythematosus.